Find a Doctor
To find your closest EVO ICL doctor, start by searching your location.
3+ million lenses distributed worldwide
Sort by:
Harry Koster, MD
Office Information
NY Vision Group - Tribeca
Office Hours
- Today
- 8:00AM-4:00PM
About this Doctor
Dr. Harry Koster is a board-certified ophthalmologist, specially trained in cornea and external diseases of the eye. He is a highly experienced refractive surgeon who has performed over 25,000 refractive procedures for patients in the New York City area. In addition, Dr. Koster has been named by his peers as a New York Super Doctor for the tenth year in a row, making him a Hall of Fame Super Doctor as described in the May 9, 2021, New York Times Magazine special supplement. Dr. Koster has also been named a Castle Connolly Top Doctor for the past seven years in a row, commencing in 2015.
Dr. Koster, a Swiss-American citizen, comes from a long tradition of skilled physicians. His grandfather, Harry Koster, was a pioneering general surgeon in Brooklyn 70 years ago, performing many innovative surgical techniques, often with limited anesthesia. Dr. Koster’s father, Robert Koster, is one of the preeminent internists in Dallas, TX. Consequently, Dr. Koster developed a deep respect for the field of medicine and for ethical patient care from an early age. He prides himself on carrying on the family tradition of excellence in medicine and in being a technically superior surgeon. Dr. Koster, along with all the staff and doctors at NY Vision Group, is dedicated to helping patients realize their best vision to help them lead healthy, fulfilling lives.
Dr. Koster is currently an assistant clinical professor at New York Eye and Ear and a Surgeon Director att SUNY College of Optometry. He is a diplomate of the American Board of Ophthalmology, a member of the Academy of Ophthalmology and a fellow of the American Society of Cataract and Refractive Surgery. He has been a member of the Medical Scientific Advisory Board of the New York Eye Bank for over 10 years. Dr. Koster is fluent in both French and Spanish. He has been in private practice in New York for over 20 years. He is an avid runner, having completed over ten NYC marathons, and lives in downtown Manhattan with his wife and two children.
Dr. Koster and NY Vision Group are happy to announce that they are the lead sponsor for NY Vision Group-Fuoriclass Racing, a New York-based amateur cycling sub-team chartered through the Century Road Club Association (CRCA). The current roster of nine racers can be found most weekdays training in Central Park early in the morning. On weekends, Fuoirclasse racers often compete in Central Park circuit races, starting as early as 5:30 a.m. In addition to racing in Central Park, Fuoirclasse teammates participate in events throughout the mid-Atlantic and Northeast region. Most of the team will race between 30 and 40 days during the March through September season.
Certification and Association
- American Board of Ophthalmology
Education
- Undergraduate Degree- Columbia College
- Medical Degree- Southwestern Medical School
- Internship- New York Hospital/Memorial Sloan Kettering Hospital
- Residency- New York Eye and Ear Hospital
- Fellowship- Hotel-Dieu in Paris, Harvard Medical School
Call today to set up a consultation for EVO ICL
516-289-9560Select Your Region
Latin America
References
1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.
2. Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125.
3. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clinical Ophthalmology. 2022;16:1541-53.
4. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.
5. Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017;11:1253-1263.
6. Naves J.S, Carracedo G, Cacho-Babillo I, Diadenosine nucleotid measurements as dry-eye score in patients after LASIK and ICL surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
7. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
8. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
9. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.
This provider locator tool is being provided by STAAR Surgical® Company (“STAAR”) solely to assist users in locating a provider who has experience with the EVO ICL family of lenses, as explained further here. Specifically, the sole criteria for inclusion in the locator is whether a provider is certified by STAAR to implant EVO ICL lenses. Users may search the locator by zip code, state, or current location. Two types of sorting functionality is available within the locator. Users are able to sort the results via distance, or by the frequency with which a healthcare provider has recently used EVO ICL lenses (e.g., within the past 12 months). Irrespective of the sorting method selected, all providers are shown in the results within the queried geographic location. The listed order of providers under any sorting method, including the initial presentation of providers in a geographic location, is based on a variety of factors, including whether the provider maintains consumer-facing information about EVO ICL lenses on its website, the breadth and quality of such information, whether it has demonstrated a commitment to training staff and offering the EVO ICL as a refractive procedure option to qualified patients, and how frequently the provider has performed procedures using the EVO ICL over the past year.
Notwithstanding the above, this provider locator tool should not be construed in any way as an endorsement or recommendation by STAAR as to the qualifications of any provider listed in this tool or the quality of medical care they can provide. STAAR makes no guarantees that using a provider from this list will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential provider. STAAR recommends that you meet and discuss the benefits and risks of the EVO ICL lens, and the procedure to implant the EVO ICL lens with the potential provider.
STAAR hereby disclaims any and all liability arising from your use of and/or reliance on the information contained in this provider locator tool.
Important Safety Information
The EVO Visian ICL Lens is intended for the correction of moderate to high nearsightedness. EVO Visian ICL and EVO Visian TICL surgery is intended to safely and effectively correct nearsightedness between -3.0 D to -15.0 D, the reduction in nearsightedness up to -20.0 D and treatment of astigmatism from 1.0 D to 4.0 D. If you have nearsightedness within these ranges, EVO Visian ICL surgery may improve your distance vision without eyeglasses or contact lenses. Because the EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses, you may require them at some point, even if you have never worn them before.
Implantation of the EVO Visian ICL is a surgical procedure, and as such, carries potentially serious risks. Please discuss the risks with your eye care professional. Complications, although rare, may include need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts.
You should NOT have EVO Visian ICL surgery if:
- Your doctor determines that the shape of your eye is not an appropriate fit for the EVO Visian ICL
- You are pregnant or nursing
- You have moderate to severe damage to the optic nerve caused by increased pressure (glaucoma)
- You do not meet the minimum endothelial cell density for your age at the time of implantation as determined by your eye doctor
- Your vision is not stable as determined by your eye doctor
Before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery. For additional information with potential benefits, risks and complications please visit DiscoverICL.com.
Feeling unsure?
We get it. Decisions like this take time to consider and research. We can help guide your decision with information that's the most relevant to you.
Do you currently wear glasses or contacts?